Development and Validation of the Nonalcoholic Fatty Liver Disease Familial Risk Score to Detect Advanced Fibrosis: A Prospective, Multicenter Study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Development and Validation of the Nonalcoholic Fatty Liver Disease Familial Risk Score to Detect Advanced Fibrosis: A Prospective, Multicenter Study

Published:2024-01 Issue:1 Volume:22 Page:81-90.e4
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Huang Daniel Q.,Ahlholm Noora,Luukkonen Panu K.,Porthan Kimmo,Amangurbanova Maral,Madamba Egbert,Bettencourt Richele,Siddiqi Harris,Cervantes Vanessa,Hernandez Christie,Lopez Scarlett J.,Richards Lisa,Nemes Katriina,Isoniemi Helena,Yki-Järvinen Hannele,Loomba Rohit^ORCID

Funder

National Medical Research Council

National Heart, Lung, and Blood Institute

Ministry of Health -Singapore

National Institute of Diabetes and Digestive and Kidney Diseases

Academy of Finland

National Center for Advancing Translational Sciences

Novo Nordisk

European Federation of Pharmaceutical Industries and Associations

Sigrid Juséliuksen Säätiö

National Heart Lung and Blood Institute Division of Intramural Research

Horizon 2020

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference27 articles.

1. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis;Riazi;Lancet Gastroenterol Hepatol,2022

2. Fibrosis progression rate in biopsy-proven nonalcoholic fatty liver disease among people with diabetes versus people without diabetes: a multicenter study;Huang;Gastroenterology,2023

3. Global epidemiology of cirrhosis — aetiology, trends and predictions;Huang;Nat Rev Gastroenterol Hepatol,2023

4. Mortality outcomes by fibrosis stage in nonalcoholic fatty liver disease: a systematic review and meta-analysis;Ng;Clin Gastroenterol Hepatol,2023

5. Sampling variability of liver biopsy in nonalcoholic fatty liver disease;Ratziu;Gastroenterology,2005

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Repeatability of vibration‐controlled transient elastography versus magnetic resonance elastography in patients with cirrhosis: A prospective study;Alimentary Pharmacology & Therapeutics;2024-06-11

2. Einfacher Risiko-Score zur Beurteilung einer Leberfibrose bei Verwandten;Zeitschrift für Gastroenterologie;2024-06

3. Hepatic Fibrosis and Cancer: The Silent Threats of Metabolic Syndrome;Diabetes & Metabolism Journal;2024-03-31

4. Prevalence and Determinants of Liver Disease in Relatives of Italian Patients With Advanced MASLD;Clinical Gastroenterology and Hepatology;2024-01

5. Prevalence of steatotic liver disease, MASLD, MetALD and significant fibrosis in people with HIV in the United States;Alimentary Pharmacology & Therapeutics;2023-12-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3